{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:22:45Z","timestamp":1788438165631,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ijcard.2018.01.039","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T00:52:54Z","timestamp":1523580774000},"page":"119-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Cardiac resynchronization therapy: How did consensus guidelines from Europe and the United States evolve in the last 15\u202fyears?"],"prefix":"10.1016","volume":"261","author":[{"given":"Giuseppe","family":"Boriani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Ziacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Nesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Battista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Placentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo Livio","family":"Malavasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Diemberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Padeletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2018.01.039_bb0005","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1053\/euhj.1999.1678","article-title":"Guidelines: making the headlines or confined to the sidelines?","volume":"20","author":"Bassand","year":"1999","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0010","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(03)14546-1","article-title":"From best evidence to best practice: effective implementation of change","volume":"362","author":"Grol","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2018.01.039_bb0015","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1111\/j.1540-8159.1994.tb03783.x","article-title":"Four chamber pacing in dilated cardiomyopathy","volume":"17","author":"Cazeau","year":"1994","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0020","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1067\/mhj.2000.110570","article-title":"A pilot experience with permanent biventricular pacing to treat advanced heart failure","volume":"140","author":"Leclercq","year":"2000","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijcard.2003.05.016","article-title":"Cardiac resynchronization by pacing: an electrical treatment of heart failure","volume":"94","author":"Boriani","year":"2004","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0030","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJM200103223441202","article-title":"Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay","volume":"344","author":"Cazeau","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ijcard.2018.01.039_bb0035","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0735-1097(02)01895-8","article-title":"Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay","volume":"39","author":"Auricchio","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0040","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa013168","article-title":"Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure","volume":"346","author":"Abraham","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0045","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.289.20.2685","article-title":"Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial","volume":"289","author":"Young","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2018.01.039_bb0050","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0735-1097(03)01042-8","article-title":"Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias","volume":"42","author":"Higgins","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0055","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1161\/01.CIR.0000146336.92331.D1","volume":"110","author":"Abraham","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.01.039_bb0060","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0065","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"Cardiac Resynchronization-Heart Failure (CARE-HF) Study investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0070","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","volume":"52","author":"Linde","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0075","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0080","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators. Cardiac-resynchronization therapy for mild-to-moderate heart failure","volume":"363","author":"Tang","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0085","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJMoa1210356","article-title":"Biventricular versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block (BLOCK HF) Trial Investigators. Biventricular pacing for atrioventricular block and systolic dysfunction","volume":"368","author":"Curtis","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0090","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1306687","article-title":"EchoCRT Study Group. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex","volume":"369","author":"Ruschitzka","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ijcard.2018.01.039_bb0095","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2459\/JCM.0000000000000147","article-title":"BLOCK HF: how far does it extend indications for cardiac resynchronization therapy?","volume":"17","author":"Boriani","year":"2016","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"key":"10.1016\/j.ijcard.2018.01.039_bb0100","doi-asserted-by":"crossref","unstructured":"Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL, Gibbons RJ, Antman EM, Alpert JS, Gregoratos G, Hiratzka LF, Faxon DP, Jacobs AK, Fuster V, Smith SC Jr; American College of Cardiology\/American Heart Association Task Force on Practice Guidelines\/North American Society for Pacing and Electrophysiology Committee to update the 1998 Pacemaker Guidelines. ACC\/AHA\/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: summary article. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (ACC\/AHA\/NASPE Committee to update the 1998 pacemaker guidelines). Circulation. 2002 Oct 15;106(16):(2145-61).","DOI":"10.1161\/01.CIR.0000035996.46455.09"},{"issue":"12","key":"10.1016\/j.ijcard.2018.01.039_bb0105","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.105.167587","volume":"112","author":"Hunt","year":"2005","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ijcard.2018.01.039_bb0110","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","volume":"26","author":"Swedberg","year":"2005","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.ijcard.2018.01.039_bb0115","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/europace\/eum189","volume":"9","author":"Vardas","year":"2007","journal-title":"Europace"},{"issue":"10","key":"10.1016\/j.ijcard.2018.01.039_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejheart.2008.08.005","volume":"10","author":"Dickstein","year":"2008","journal-title":"Eur. J. Heart Fail."},{"issue":"21","key":"10.1016\/j.ijcard.2018.01.039_bb0125","volume":"117","author":"Epstein","year":"2008","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ijcard.2018.01.039_bb0130","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1161\/CIRCULATIONAHA.109.192065","volume":"119","author":"Hunt","year":"2009","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ijcard.2018.01.039_bb0135","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/eurjhf\/hfq192","volume":"12","author":"Dickstein","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2012.12.014","volume":"61","author":"Epstein","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0145","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","volume":"14","author":"JJ","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0150","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1161\/CIR.0b013e31829e8807","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.01.039_bb0155","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.ijcard.2018.01.039_bb0160","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"issue":"13","key":"10.1016\/j.ijcard.2018.01.039_bb0165","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/eurheartj\/ehn133","article-title":"Multicentre Longitudinal Observational Study (MILOS) Group. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation","volume":"29","author":"Gasparini","year":"2008","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ijcard.2018.01.039_bb0170","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jchf.2013.06.003","article-title":"Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry)","volume":"1","author":"Gasparini","year":"2013","journal-title":"JACC Heart Fail."},{"issue":"7","key":"10.1016\/j.ijcard.2018.01.039_bb0175","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ejhf.269","article-title":"Validation of a simple risk stratification tool for patients implanted with cardiac resynchronization therapy: the VALID-CRT risk score","volume":"17","author":"Gasparini","year":"2015","journal-title":"Eur. J. Heart Fail."},{"issue":"2","key":"10.1016\/j.ijcard.2018.01.039_bb0180","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004471","article-title":"Effects of upgrade versus de novo cardia resynchronization therapy on clinical response and long-term survival: results from a multicenter study","volume":"10","author":"Vamos","year":"2017","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"2","key":"10.1016\/j.ijcard.2018.01.039_bb0185","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1586\/erd.10.80","article-title":"From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems","volume":"8","author":"Diemberger","year":"2011","journal-title":"Expert Rev. Med. Devices"},{"issue":"6","key":"10.1016\/j.ijcard.2018.01.039_bb0190","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/ejhf.509","volume":"18","author":"Boriani","year":"2016","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2018.01.039_bb0195","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/ejhf.743","article-title":"Patient outcome after implant of a cardioverter defibrillator in the 'real world': the key role of co-morbidities","volume":"19","author":"Boriani","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0200","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.jacc.2005.08.034","article-title":"There is plenty of room for cardiac resynchronization therapy devices without back-up defibrillators in the electrical treatment of heart failure","volume":"46","author":"Daubert","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0205","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1136\/heartjnl-2012-301845","article-title":"Cost-effectiveness of cardiac resynchronisation therapy","volume":"98","author":"Boriani","year":"2012","journal-title":"Heart"},{"issue":"Suppl. 2","key":"10.1016\/j.ijcard.2018.01.039_bb0210","doi-asserted-by":"crossref","first-page":"ii59","DOI":"10.1093\/europace\/eur080","article-title":"Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario","volume":"13","author":"Boriani","year":"2011","journal-title":"Europace"},{"issue":"10","key":"10.1016\/j.ijcard.2018.01.039_bb0215","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/europace\/eut133","article-title":"Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon","volume":"15","author":"Boriani","year":"2013","journal-title":"Europace"},{"issue":"13","key":"10.1016\/j.ijcard.2018.01.039_bb0220","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0225","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/jce.13204","article-title":"Implantable cardioverter defibrillators for primary prevention of mortality in patients with nonischemic cardiomyopathy a meta-analysis of randomized controlled trials","volume":"28","author":"Stavrakis","year":"2017","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0230","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.116.026056","article-title":"Implantable cardioverter-defibrillator for nonischemic cardiomyopathy: an updated meta-analysis","volume":"135","author":"Golwala","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.01.039_bb0235","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jamacardio.2017.0630","article-title":"Primary prevention implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy: a meta-analysis","volume":"2","author":"Al-Khatib","year":"2017","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0240","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/ejhf.1080","article-title":"Extending survival by reducing sudden death with implantable cardioverter defibrillators: a challenging clinical issue in non-ischaemic and ischaemic cardiomyopathies","volume":"20","author":"Boriani","year":"2018","journal-title":"Eur. J. Heart Fail."},{"issue":"10","key":"10.1016\/j.ijcard.2018.01.039_bb0245","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jacc.2017.07.712","article-title":"Outcomes of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy","volume":"70","author":"Leyva","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"Suppl. 3","key":"10.1016\/j.ijcard.2018.01.039_bb0250","article-title":"The EHRA white book","volume":"14","author":"Arribas","year":"2012","journal-title":"Europace"},{"issue":"Suppl. 3","key":"10.1016\/j.ijcard.2018.01.039_bb0255","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1093\/europace\/euw244","article-title":"Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 report from the European Heart Rhythm Association","volume":"18","author":"Raatikainen","year":"2016","journal-title":"Europace"},{"issue":"25","key":"10.1016\/j.ijcard.2018.01.039_bb0260","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/eurheartj\/eht031","article-title":"Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association","volume":"34","author":"Boriani","year":"2013","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.ijcard.2018.01.039_bb0265","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/ejhf.569","article-title":"Prognostic implications of mitral regurgitation in patients after cardiac resynchronization therapy","volume":"18","author":"Cipriani","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0270","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/CIRCULATIONAHA.108.773838","article-title":"Get with the guidelines steering committee and hospitals. Use of cardiac resynchronization therapy in patients hospitalized with heart failure","volume":"118","author":"Piccini","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.01.039_bb0275","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ahj.2009.10.011","article-title":"Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF","volume":"158","author":"Curtis","year":"2009","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0280","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/europace\/euq176","article-title":"RERAI (Registry of Emilia Romagna on Arrhythmia Interventions) Investigators. Implantable electrical devices for prevention of sudden cardiac death: data on implant rates from a \u2018real world\u2019 regional registry","volume":"12","author":"Boriani","year":"2010","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.ijcard.2018.01.039_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healthpol.2015.11.001","article-title":"Implant rates of cardiac implantable electrical devices in Europe: a systematic literature review","volume":"120","author":"Valzania","year":"2016","journal-title":"Health Policy"},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2018.01.039_bb0290","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/hec.3470","article-title":"Investigating regional variation of cardiac implantable electrical device implant rates in European healthcare systems: what drives differences?","volume":"26","author":"Torbica","year":"2017","journal-title":"Health Econ."},{"key":"10.1016\/j.ijcard.2018.01.039_bb0295","article-title":"Five year trend (2008\u20132012) in cardiac implantable electrical device utilization in five European nations: a case study in cross-country comparisons using administrative databases","author":"Banks","year":"2017","journal-title":"Europace"},{"issue":"10","key":"10.1016\/j.ijcard.2018.01.039_bb0300","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jacc.2014.06.1178","article-title":"20\u202fyears of cardiac resynchronization therapy","volume":"64","author":"Leyva","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2018.01.039_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2011.11.014","article-title":"Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials","volume":"163","author":"Sipahi","year":"2012","journal-title":"Am. Heart J."},{"issue":"46","key":"10.1016\/j.ijcard.2018.01.039_bb0310","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1093\/eurheartj\/eht290","article-title":"An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure","volume":"34","author":"Cleland","year":"2013","journal-title":"Eur. Heart J."},{"issue":"18","key":"10.1016\/j.ijcard.2018.01.039_bb0315","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/heartjnl-2014-306811","article-title":"Cardiac resynchronisation therapy is not associated with a reduction in mortality or heart failure hospitalisation in patients with non-left bundle branch block QRS morphology: meta-analysis of randomised controlled trials","volume":"101","author":"Cunnington","year":"2015","journal-title":"Heart"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317332448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317332448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T02:01:08Z","timestamp":1533175268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527317332448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":63,"alternative-id":["S0167527317332448"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.01.039","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac resynchronization therapy: How did consensus guidelines from Europe and the United States evolve in the last 15\u202fyears?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.01.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}